Skip to content
10-K

Annual Report

GUIDED THERAPEUTICS INC GTHP

0001477932-23-001899

← back to feed
Filed
Mar 30, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 27, 2023 50.51M sh
Long Term Debt FY 2022 · Dec 31, 2022 $0
Long Term Debt FY 2022 · Dec 31, 2021 $22K
Cash And Equivalents FY 2022 · Dec 31, 2022 $2.31M
Cash And Equivalents FY 2022 · Dec 31, 2021 $643K
Shares Diluted FY 2022 · Dec 31, 2021 13.38M sh
Capex FY 2022 · Dec 31, 2021 $14K
Operating Cash Flow FY 2022 · Dec 31, 2021 −$1.59M
Current Liabilities FY 2022 · Dec 31, 2021 $5.69M
Total Liabilities FY 2022 · Dec 31, 2021 $7.49M
Current Assets FY 2022 · Dec 31, 2021 $1.64M
Total Assets FY 2022 · Dec 31, 2021 $2.04M
Eps Diluted FY 2022 · Dec 31, 2021 −$0.18
Eps Basic FY 2022 · Dec 31, 2021 −$0.18
Sga Expense FY 2022 · Dec 31, 2021 $2.17M
Rd Expense FY 2022 · Dec 31, 2021 $69K
Net Income FY 2022 · Dec 31, 2021 −$2.07M
Operating Income FY 2022 · Dec 31, 2021 −$2.36M
Gross Profit FY 2022 · Dec 31, 2021 $20K
Revenue FY 2022 · Dec 31, 2021 $81K
Stockholders Equity FY 2022 · Dec 31, 2020 −$10.86M